1. Home
  2. TMDX vs SXI Comparison

TMDX vs SXI Comparison

Compare TMDX & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • SXI
  • Stock Information
  • Founded
  • TMDX 1998
  • SXI 1955
  • Country
  • TMDX United States
  • SXI United States
  • Employees
  • TMDX N/A
  • SXI N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SXI Industrial Machinery/Components
  • Sector
  • TMDX Health Care
  • SXI Industrials
  • Exchange
  • TMDX Nasdaq
  • SXI Nasdaq
  • Market Cap
  • TMDX 2.7B
  • SXI 2.5B
  • IPO Year
  • TMDX 2019
  • SXI N/A
  • Fundamental
  • Price
  • TMDX $62.71
  • SXI $202.07
  • Analyst Decision
  • TMDX Buy
  • SXI Strong Buy
  • Analyst Count
  • TMDX 11
  • SXI 3
  • Target Price
  • TMDX $116.10
  • SXI $227.00
  • AVG Volume (30 Days)
  • TMDX 1.9M
  • SXI 41.6K
  • Earning Date
  • TMDX 10-28-2024
  • SXI 01-30-2025
  • Dividend Yield
  • TMDX N/A
  • SXI 0.64%
  • EPS Growth
  • TMDX N/A
  • SXI N/A
  • EPS
  • TMDX 0.94
  • SXI 6.09
  • Revenue
  • TMDX $401,090,000.00
  • SXI $706,325,000.00
  • Revenue This Year
  • TMDX $82.52
  • SXI $12.37
  • Revenue Next Year
  • TMDX $25.91
  • SXI $9.27
  • P/E Ratio
  • TMDX $70.11
  • SXI $32.89
  • Revenue Growth
  • TMDX 109.09
  • SXI N/A
  • 52 Week Low
  • TMDX $60.80
  • SXI $140.04
  • 52 Week High
  • TMDX $177.37
  • SXI $212.66
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 31.44
  • SXI 47.87
  • Support Level
  • TMDX $60.80
  • SXI $198.40
  • Resistance Level
  • TMDX $66.44
  • SXI $212.65
  • Average True Range (ATR)
  • TMDX 4.10
  • SXI 3.95
  • MACD
  • TMDX 0.50
  • SXI -1.56
  • Stochastic Oscillator
  • TMDX 13.30
  • SXI 19.09

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

Share on Social Networks: